Gennex Lab.

57
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
13.48
-0.01 (-0.07%)
BSENSE

Dec 05

BSE+NSE Vol: 2.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
156.00
98.00
71.00
65.00
63.00
59.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
18.00
11.00
6.00
4.00
4.00
4.00
Net Sales
137.00
86.00
65.00
61.00
59.00
55.00
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-9.00
-6.00
-1.00
1.00
-1.00
Raw Materials Consumed
100.00
57.00
46.00
40.00
34.00
35.00
Power & Fuel Cost
4.00
4.00
4.00
3.00
3.00
3.00
Employee Cost
8.00
7.00
7.00
6.00
7.00
6.00
Operating Expenses
3.00
2.00
2.00
1.00
2.00
3.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
2.00
1.00
2.00
2.00
2.00
1.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
2.00
2.00
1.00
2.00
1.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
121.00
69.00
60.00
55.00
53.00
52.00
Operating Profit (PBDIT) excl Other Income
16.00
17.00
4.00
5.00
6.00
3.00
Other Income
10.00
4.00
3.00
1.00
0.00
0.00
Operating Profit (PBDIT)
27.00
21.00
8.00
6.00
7.00
4.00
Interest
3.00
3.00
1.00
0.00
0.00
0.00
Profit before Depriciation and Tax
23.00
18.00
7.00
5.00
6.00
3.00
Depreciation
1.00
2.00
0.00
0.00
0.00
1.00
Profit Before Taxation & Exceptional Items
21.00
16.00
6.00
5.00
5.00
2.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
21.00
16.00
6.00
5.00
5.00
2.00
Provision for Tax
3.00
3.00
1.00
1.00
1.00
0.00
Profit After Tax
18.00
13.00
4.00
3.00
4.00
1.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
38.00
28.00
23.00
19.00
15.00
13.00
Profit Available for appropriations
56.00
41.00
28.00
23.00
19.00
15.00
Appropriations
56.00
41.00
28.00
23.00
19.00
15.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
0.80
0.70
0.42
0.31
0.32
0.15
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 59.03% vs 32.18% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -1.84% vs 262.90% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 17.28% vs 127.21% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 37.55% vs 167.74% in Mar 2024

Compare Profit and Loss Results of Gennex Lab.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
156.00
367.00
-211.00
-57.49%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
18.00
0.00
18.00
0%
Net Sales
137.00
367.00
-230.00
-62.67%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-14.00
11.00
78.57%
Raw Materials Consumed
100.00
185.00
-85.00
-45.95%
Power & Fuel Cost
4.00
13.00
-9.00
-69.23%
Employee Cost
8.00
53.00
-45.00
-84.91%
Operating Expenses
3.00
31.00
-28.00
-90.32%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
24.00
-22.00
-91.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
6.00
-4.00
-66.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
121.00
326.00
-205.00
-62.88%
Operating Profit (PBDIT) excl Other Income
16.00
41.00
-25.00
-60.98%
Other Income
10.00
5.00
5.00
100.00%
Operating Profit (PBDIT)
27.00
46.00
-19.00
-41.30%
Interest
3.00
6.00
-3.00
-50.00%
Profit before Depriciation and Tax
23.00
39.00
-16.00
-41.03%
Depreciation
1.00
15.00
-14.00
-93.33%
Profit Before Taxation & Exceptional Items
21.00
23.00
-2.00
-8.70%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
23.00
-2.00
-8.70%
Provision for Tax
3.00
6.00
-3.00
-50.00%
Profit After Tax
18.00
17.00
1.00
5.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
38.00
140.00
-102.00
-72.86%
Profit Available for appropriations
56.00
157.00
-101.00
-64.33%
Appropriations
56.00
157.00
-101.00
-64.33%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.797
3.54
-2.74
-77.49%
Profit And Loss - Net Sales
Net Sales 137.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 59.03% vs 32.18% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1.84% vs 262.90% in Mar 2024

Profit And Loss - Interest
Interest 3.61 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.28% vs 127.21% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 18.12 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.55% vs 167.74% in Mar 2024